###begin article-title 0
###xml 84 92 <span type="species:ncbi:9606">Patients</span>
Expression Profiling of PBMC-based Diagnostic Gene Markers Isolated from Vasculitis Patients
###end article-title 0
###begin p 1
Edited by Mitsuo Oshimura.
###end p 1
###begin p 2
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 2
###begin p 3
###xml 442 450 <span type="species:ncbi:9606">patients</span>
###xml 597 605 <span type="species:ncbi:9606">patients</span>
###xml 708 716 <span type="species:ncbi:9606">patients</span>
###xml 838 846 <span type="species:ncbi:9606">patients</span>
###xml 906 921 <span type="species:ncbi:10090">transgenic mice</span>
###xml 952 957 <span type="species:ncbi:9606">human</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
Vasculitis (angiitis) is a systemic autoimmune disease that often causes fatal symptoms. We aimed to isolate cDNA markers that would be useful for diagnosing not only vasculitis but also other autoimmune diseases. For this purpose, we used stepwise subtractive hybridization and cDNA microarray analyses to comprehensively isolate the genes whose expressions are augmented in peripheral blood mononuclear cells (PBMCs) pooled from vasculitis patients. Subsequently, we used quantitative real-time polymerase chain reaction (qRT-PCR) to examine the mRNA levels of each candidate gene in individual patients. These analyses indicated that seven genes exhibit remarkably augmented expression in many vasculitis patients. Of these genes, we analyzed G0/G1 switch gene 2 (G0S2) further because G0S2 expression is also enhanced in the PBMCs of patients with systemic lupus erythematodes (SLE). We generated G0S2 transgenic mice that ubiquitously overexpress human G0S2. Although we did not observe any obvious vasculitis-related histopathologic findings in these mice, these mice are unhealthy as they produce only few offspring and showed elevated serum levels of two autoimmunity-related antibodies, anti-nuclear antibody, and anti-double strand DNA antibody. Thus, our large-scale gene profiling study may help finding sensitive and specific DNA markers for diagnosing autoimmune diseases including vasculitis and SLE.
###end p 3
###begin title 4
Key words
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 466 467 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C1">1</xref>
###xml 466 467 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C1">1</xref></sup>
###xml 924 925 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C2">2</xref>
###xml 926 927 914 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C3">3</xref>
###xml 924 927 912 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C2">2</xref>,<xref ref-type="bibr" rid="DSN014C3">3</xref></sup>
###xml 1209 1216 <span type="species:ncbi:9606">patient</span>
There are approximately10 different disorders that are classified as vasculitis (also known as angiitis). Vasculitis is a systemic autoimmune disease characterized by the chronic inflammation of systemic blood vessels, veins, and arteries of all types and sizes. This often causes symptoms that can rapidly induce death, such as the formation of blood clots (thrombosis), restriction of oxygenated blood supply (ischemia), and irreversible injury to affected organs.1 Although immune system disturbances appear to be the main cause of the disease, the pathogenesis of vasculitis is not fully understood. The diagnosis and treatment of vasculitis was recently greatly aided by the observation that three vasculitis disorders, namely Wegener's granulomatosis (WG), microscopic polyangiitis (MPA), and Churg-Strauss syndrome (CSS), are characterized by the presence of circulating antineutrophil cytoplasmic antibodies (ANCAs).2,3 Two different types of ANCA have been identified. C-ANCA targets proteinase-3 and is most frequently found in WG, whereas P-ANCA, which targets myeloperoxidase, is most frequently detected in MPA and CSS. Consequently, enzyme immunosorbent assays (EIA) that examine the ability of patient serum to bind to these enzymes can be used to diagnose WG, MPA, and CSS. However, diagnoses made on the basis of positive EIAs will still need to be confirmed by biopsies. Moreover, many other vasculitis disorders are not characterized by the presence of ANCAs. Thus, the diagnosis of vasculitis disorders requires the identification of more convenient and generally applicable diagnostic markers. The identification of these markers may also provide insights into the pathogenesis behind this disorder and improve the therapy of vasculitis.
###end p 6
###begin p 7
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C4">4</xref>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C4">4</xref></sup>
###xml 164 165 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C5">5</xref>
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C5">5</xref></sup>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C6">6</xref>
###xml 467 468 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C6">6</xref></sup>
###xml 1290 1294 1290 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 1318 1322 1318 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 1343 1346 1343 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBD</italic>
###xml 1377 1381 1377 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AREG</italic>
###xml 1416 1421 1416 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1R2</italic>
###xml 1424 1437 1424 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin C</italic>
###xml 1462 1468 1462 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS10</italic>
###xml 1498 1502 1498 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 644 652 <span type="species:ncbi:9606">patients</span>
###xml 671 678 <span type="species:ncbi:9606">patient</span>
###xml 826 834 <span type="species:ncbi:9606">patients</span>
###xml 878 886 <span type="species:ncbi:9606">patients</span>
###xml 1226 1234 <span type="species:ncbi:9606">patients</span>
###xml 1640 1655 <span type="species:ncbi:10090">transgenic mice</span>
We have isolated putative gene markers that are characteristic to the autoimmune diseases, such as systemic lupus erythematodes (SLE)4 and rheumatoid arthritis (RA)5, using peripheral blood mononuclear cells (PBMCs). Here, we sought to identify new gene markers that can distinguish the autoimmune disease, in particular vasculitis, from other diseases with high specificity when PBMCs serve as the sample. For this purpose, we used the stepwise subtraction technique6 and high-density oligonucleotide microarrays to isolate those genes that show dramatically upregulated expression commonly in the pooled PBMC mRNAs of varieties of vasculitis patients regardless of the patient's symptom, active, or inactive phase when compared with normal volunteer PBMC mRNAs. To identify the genes that are upregulated in many vasculitis patients, we selected and mixed the PBMC mRNAs from patients with one of the following seven vasculitis disorders: WG, MPA, Takayasu's arteritis (TA), allergic granulomatous angiitis (AGA), malignant RA (MRA = rheumatoid vasculitis), giant cell arteritis (GCA), and polyarteritis nodosa (PN). We found that the following seven genes are commonly unpregulated in the PBMCs of many of these vasculitis patients regardless of their symptoms: early growth response 1 (EGR1), G0/G1 switch gene 2 (G0S2), hemoglobin delta (HBD), amphiregulin (also known as AREG), interleukin-1 receptor type II (IL1R2), calgranulin C, and a novel gene named TVAS10. Of these genes, we selected G0S2 for further analysis because its physiological functions are poorly understood. We prepared anti-G0S2 antibodies and then generated G0S2 transgenic mice and examined their phenotype. We propose that the vasculitis gene markers we identified here may be useful for the future diagnosis of vasculitis.
###end p 7
###begin title 8
Materials and methods
###end title 8
###begin title 9
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects and ethical considerations
###end title 9
###begin p 10
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C1">1</xref>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C1">1</xref></sup>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 350 362 <span type="species:ncbi:9606">participants</span>
###xml 457 464 <span type="species:ncbi:9606">patient</span>
All systemic vasculitis patients used in this study were diagnosed according to a previously documented proposal (the ACR criteria and the CHCC criteria).1 This study was reviewed and approved by the Internal Review Board of the Research Institute for Microbial Diseases, Osaka University. Accordingly, written informed consent was obtained from all participants before their PBMCs were obtained. Serum samples were consecutively obtained regardless of the patient's symptom, active, or inactive phase.
###end p 10
###begin title 11
Statistical analysis
###end title 11
###begin p 12
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F2">2</xref>
###xml 129 130 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Significant differences were determined by using Mann-Whitney U-test (Figs. 1 and 2B, ). The data are expressed as means +/- SE. P-value of <0.05 or <0.01 was considered to be statistically significant.
###end p 12
###begin p 13
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS/TAC</italic>
###xml 142 143 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC-1</italic>
###xml 160 161 160 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 169 175 169 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC-40</italic>
###xml 179 180 179 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 182 185 182 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBD</italic>
###xml 187 194 187 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC-106</italic>
###xml 198 199 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 201 213 201 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Amphiregulin</italic>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC-9</italic>
###xml 228 229 228 229 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS10</italic>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC-30</italic>
###xml 843 844 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 300 307 <span type="species:ncbi:9606">patient</span>
###xml 746 753 <span type="species:ncbi:9606">patient</span>
mRNA expression of selected TAS/TAC genes in the PBMCs from individual vasculitis patients and normal volunteers. qRT-PCR analyses show that (A) EGR1 (TAC-1), (B) G0S2 (TAC-40), (C) HBD (TAC-106), (D) Amphiregulin (TAC-9), and (E) TVAS10 (TAC-30) are generally upregulated in the PBMCs of vasculitis patient (circles) but not in the PBMCs of normal volunteers (triangles). Each symbol denotes the mean value of a sample analyzed in triplicate. The leftmost filled circle signifies an RNA sample from the PBMCs of a healthy volunteer (male, age 52), which was used as a standard sample and whose expression level was set to 1.0. It allowed us to compare all of the expression profiles tested in this study. Average +/- SE values of the vasculitis patient and normal volunteer groups are shown in the right-hand graphs and differ significantly (P < 0.01).
###end p 13
###begin p 14
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 38 39 38 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 345 346 345 346 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 20 35 <span type="species:ncbi:10090">transgenic mice</span>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 226 231 <span type="species:ncbi:9606">human</span>
###xml 297 302 <span type="species:ncbi:10090">mouse</span>
###xml 327 342 <span type="species:ncbi:10090">transgenic mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
Family tree of G0S2 transgenic mice. (A) Of the 61 mice tested in the first trial, six G0S2 transgenic mouse lines were generated. They all died except for the GTG1b line, which was not useful for further analysis because the human G0S2 gene was introduced on the Y chromosome; consequently, this mouse only produced male G0S2 transgenic mice. (B) Of the 22 mice tested in the third trial, three G0S2 transgenic mouse lines were generated. The only surviving GTG3a line is now under large scale propagation to establish a strain.
###end p 14
###begin title 15
###xml 53 68 <span type="species:ncbi:10090">transgenic mice</span>
Transgene vector construction and production of G0S2 transgenic mice
###end title 15
###begin p 16
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C4">4</xref>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C4">4</xref></sup>
###xml 115 118 115 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 147 150 147 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 277 280 277 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 378 381 378 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C7">7</xref>
###xml 528 529 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C7">7</xref></sup>
###xml 534 537 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 606 609 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 928 931 922 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 933 936 927 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hin</italic>
###xml 1118 1119 1112 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C7">7</xref>
###xml 1118 1119 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C7">7</xref></sup>
###xml 1477 1480 1471 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 668 675 <span type="species:ncbi:9031">chicken</span>
###xml 728 731 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 836 843 <span type="species:ncbi:9031">chicken</span>
###xml 872 875 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1054 1058 <span type="species:ncbi:10090">mice</span>
###xml 1716 1720 <span type="species:ncbi:10090">mice</span>
###xml 1745 1749 <span type="species:ncbi:10090">mice</span>
###xml 1827 1832 <span type="species:ncbi:9606">human</span>
###xml 1911 1916 <span type="species:ncbi:10090">mouse</span>
To construct the transgene vector pCX-G0S2, the human G0S2 ORF was cloned from a SLE cDNA library4 by PCR with the EcoRI site-bearing primers G0S2-EcoRI-5'F (5'-TATGAATTCGCCACCATGGAAACGGTCCAGGAGCTGATC-3') and G0S2-EcoRI-3'R (5'-ATAGAATTCCTAGGAGGCGTGCTGCCGGTTGGAC-3'). The G0S2-EcoRI-5'F primer contains the Kozak sequence ahead of the start codon of G0S2 cDNA, whereas the G0S2-EcoRI-3'R primer contains the stop codon of G0S2 cDNA. The sequence of the amplified product was confirmed by DNA sequencing. As previously described,7 the EcoRI-digested fragment of the amplified G0S2 ORF was inserted into the EcoRI site of the pCAGGS expression vector, which possesses a chicken beta-actin promoter and a cytomegalovirus enhancer (CMV-IE enhancer). The resulting construct was designated pCX-G0S2. To prepare the G0S2 fragment bearing the chicken beta-actin promoter and the CMV-IE enhancer for injection into fertilized eggs, the SalI/HindIII fragment of pCX-G0S2 was purified by electrophoresis and agarose gel extraction. The G0S2 transgenic embryos and mice were generated according to previously described protocols.7 Briefly, the purified DNA fragments were injected into B6D2F1x B6D2F1 fertilized eggs. The incorporation of the transgene was examined by the genomic PCR analysis using DNA extracted from the tail and the pCX-G0S2-1685F (5'-GCTGGTTGTTGTGCTGTCTCATCA-3') and pCX-G0S2-2161R (5'-GCCAGAAGTCAGATGCTCAAGGGGCTTCA-3') primers. The PCR conditions involved TaKaRa Ex Taq polymerase (Takara, Shiga, Japan) and a pre-heating step (95degreesC for 2 min), 30 reaction step cycles (95degreesC for 30 s, 58degreesC for 30 s, 72degreesC for 1 min), and a final elongation step (72degreesC for 5 min). The founder mice were mated with C57BL/6 mice and both the transmittance of the transgene and the successful expression of human G0S2 protein were examined by western blot analysis of total cell extracts of mouse tails using one of the anti-G0S2 monoclonal antibodies (clone #3-1) we generated (see section 3.4 and ).
###end p 16
###begin title 17
Histological examination
###end title 17
###begin p 18
###xml 420 421 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C8">8</xref>
###xml 420 421 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C8">8</xref></sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 63 68 <span type="species:ncbi:10090">Mouse</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
C57BL/6 mice were purchased from Japan SLC (Hamamatsu, Japan). Mouse tissues were fixed immediately after removal with 4% paraformaldehyde, then embedded in paraffin, and cut into sections (4 microm thick). Some sections were stained with hematoxiln and eosin according to standard procedures, whereas others were stained with the clone #3-1 monoclonal anti-G0S2 antibody according to the previously described procedure.8 To evaluate the immunostain, sections of the same organs from G0S2-TG and C57BL/6 mice were processed at the same time. When the immunoreactive signals in the former sections were substantially stronger than those in the latter, they were considered to indicate the exogenic G0S2 proteins produced from the transgene.
###end p 18
###begin title 19
In situ hybridization
###end title 19
###begin p 20
###xml 237 245 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 621 628 621 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 313 318 <span type="species:ncbi:9606">human</span>
Sections were processed in the Genostaff laboratory (Tokyo, Japan) by using the DIG RNA labeling and detection kits (Roche Diagnostics, Mannheim, Germany). Briefly, G0S2 antisense and sense (negative control) RNA probes were prepared by in vitro transcription of the pBluescript vector containing the full-length human G0S2 cDNA according to the manufacturer's instructions. Hybridized signals were colored blue with 4-nitro blue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl-phosphate as a substrate of alkaline phosphatase. The sense probe did not yield any significant stains. Further information concerning the in situ hybridization (ISH) method is available on request.
###end p 20
###begin title 21
Serologic examination
###end title 21
###begin p 22
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Approximately 200 microl of peripheral blood per mouse were collected from the orbital plexus under anesthesia and were left for 1 h to coagulate. After centrifugation, approximately20 microl sera were obtained. The sera were frozen at -20degreesC and sent to the Mitsubishi Kagaku BCL laboratory (Tokyo, Japan), where each serum was diluted 500 times and analyzed for the levels of anti-nuclear and anti-double strand (ds) DNA antibodies by fluorescent antibody tests or enzyme immunoassays.
###end p 22
###begin title 23
Results
###end title 23
###begin title 24
Identification of vasculitis-specific genes by stepwise subtraction and DNA microarray analysis
###end title 24
###begin p 25
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C9">9</xref>
###xml 424 425 424 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C9">9</xref></sup>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C6">6</xref>
###xml 583 584 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C6">6</xref></sup>
###xml 860 861 860 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F3">3</xref>
###xml 1039 1040 1039 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F3">3</xref>
###xml 1130 1133 1130 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 1213 1216 1213 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 1275 1276 1275 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSN014TB1">1</xref>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 234 242 <span type="species:ncbi:9606">patients</span>
###xml 271 278 <span type="species:ncbi:9606">patient</span>
###xml 1109 1117 <span type="species:ncbi:9606">patients</span>
To isolate the putative vasculitis-specific genes that are commonly upregulated in the PBMCs of vasculitis patients, we first used our stepwise subtractive hybridization method. PBMC samples were obtained from vasculitis patients (50 patients in total) regardless of the patient's symptom, active, or inactive phase, and a cDNA library was prepared from their pooled mRNAs by the linker-primer method using a pAP3neo vector.9 Stepwise subtractive hybridization was then performed using the biotinylated pooled mRNAs from the PBMCs of eight normal volunteers, as described previously.6 This generated a library of genes that are upregulated in only vasculitis PBMCs. To examine whether these genes are actually upregulated in vasculitis but not normal PBMCs, we performed northern blot analysis using the pooled mRNAs from the vasculitis and normal PBMCs (Fig. 3A). For the cDNA clones whose expression levels were too low for detection by northern blot analysis, we examined their expression in vasculitis and normal PBMCs by RT-PCR (Fig. 3B). The 29 genes that were confirmed to be upregulated in vasculitis patients were called TAS after transcript augmented in vasculitis isolated by stepwise-subtraction. The TAS genes and their accession numbers are summarized in Table 1.
###end p 25
###begin p 26
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 95 96 95 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 109 110 109 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSN014TB1">1</xref>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 492 495 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 183 191 <span type="species:ncbi:9606">patients</span>
mRNA expression levels of the TAS genes. Individual TAS genes were subjected to northern blot (A) or RT-PCR (B) analysis to confirm they are upregulated in the PBMCs of 50 vasculitis patients (A) but not in the PBMCs of eight normal volunteers (N). Table 1 provides the names of the TAS genes. GAPDH was also analyzed as a loading control. The annealing temperature for RT-PCR was always 58degreesC and amplification occurred over 30 cycles. The sequences of the primers used to identify the TAS genes are presented in .
###end p 26
###begin p 27
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 97 104 <span type="species:ncbi:9606">patient</span>
List of stepwise subtraction identified TAS genes that show upregulated expression in vasculitis patient PBMCs
###end p 27
###begin p 28
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F3">3</xref>
###xml 210 218 <span type="species:ncbi:9606">patients</span>
The expression levels of the TAS genes were examined by northern blot (Fig. 1A) and/or RT-PCR (Fig. 1B). The underlined genes were subjected to qRT-PCR to determine their generality of expression in vasculitis patients but not normal volunteers (Fig. 3).
###end p 28
###begin p 29
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F4">4</xref>
###xml 470 473 470 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC</italic>
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC</italic>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSN014TB2">2</xref>
###xml 645 650 645 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DUSP1</italic>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1R2</italic>
###xml 705 708 705 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 713 716 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC</italic>
###xml 784 788 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS</italic>
###xml 431 438 <span type="species:ncbi:9606">patient</span>
To increase the number of putative vasculitis-specific genes, we also performed a genome-wide complementary DNA microarray analysis using the Agilent Hu44K array with the same pooled vasculitis and normal PBMC RNA samples. When we tested the top 402 genes from the microarray list of vasculitis-upregulated genes (data not shown) by RT-PCR, we identified 63 genes whose expression levels are dramatically upregulated in vasculitis patient PBMCs (Fig. 4). We called them TAC after transcript augmented in vasculitis isolated by cDNA-microarray. The TAC genes and their accession numbers are summarized in Table 2. Dual specificity phosphatase 1 (DUSP1) and IL1R2 were identified by both methods. Of the 92 TAS and TAC genes, 30 genes are uncharacterized genes. These are designated as TVAS after transcript increased in vasculitis.
###end p 29
###begin p 30
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC</italic>
###xml 52 55 52 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC</italic>
###xml 620 623 584 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
mRNA expression levels of the TAC genes. Individual TAC genes were subjected to RT-PCR analysis to confirm they are upregulated in the PBMCs of 50 vasculitis patients (A) but not in the PBMCs of eight normal volunteers (N). GAPDH was also analyzed as a loading control. The annealing temperature and amplification cycles for RT-PCR were always 50degreesC and 35 cycles, respectively, with the exception of the reactions denoted by a (55degreesC, 40 cycles), b (50degreesC, 30 cycles), c (58degreesC, 27 cycles), d (50degreesC, 40 cycles), and e (58degreesC, 30 cycles). The sequences of the primers used to identify the TAS genes are presented in .
###end p 30
###begin p 31
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC</italic>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
List of microarray identified TAC genes that show upregulated expression in the PBMCs of vasculitis patients
###end p 31
###begin p 32
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F2">2</xref>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F3">3</xref>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
The expression levels were examined by RT-PCR (Fig. 2). The underlined genes were subjected to qRT-PCR to determine their generality of expression in vasculitis patients but not normal volunteers (Fig. 3).
###end p 32
###begin title 33
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Expression profiles of vasculitis-upregulated genes in individual patients
###end title 33
###begin p 34
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS</italic>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC</italic>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSN014TB1">1</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSN014TB2">2</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 859 860 859 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C4">4</xref>
###xml 859 860 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C4">4</xref></sup>
###xml 868 869 868 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C5">5</xref>
###xml 868 869 868 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C5">5</xref></sup>
###xml 1019 1020 1019 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C4">4</xref>
###xml 1019 1020 1019 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C4">4</xref></sup>
###xml 1028 1029 1028 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C5">5</xref>
###xml 1028 1029 1028 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C5">5</xref></sup>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 367 375 <span type="species:ncbi:9606">patients</span>
###xml 981 989 <span type="species:ncbi:9606">patients</span>
###xml 1002 1010 <span type="species:ncbi:9606">patients</span>
To determine whether these vasculitis-specific candidate genes are indeed upregulated in patients suffering from WG, MPA, TA, AGA, MRA, GCA, or PN and thus are general markers of vasculitis, we subjected 25 of the TAS and TAC genes (underlined in Tables 1 and 2) to quantitative RT-PCR (qRT-PCR) using PBMC RNA samples from indicated numbers of individual vasculitis patients and normal volunteers as negative controls (Fig. 1 and ). In every qRT-PCR, a standard RNA (denoted as normal with a relative intensity of 1.0) from the PBMCs of a healthy volunteer (male, age 52) was used (see the leftmost filled circle in Fig. 1A-E); this allowed us to compare the expression profiles of the genes tested in this study. It also allowed us to compare the expression profiles of the genes in this study with those of other genes tested in our previous studies on SLE4 and RA.5 With this experiment, we expected to isolate those genes that are highly expressed not only in many vasculitis patients but also in patients with SLE4 and RA;5 the identification of such marker genes may be useful as sensitive and specific diagnostic tools.
###end p 34
###begin p 35
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS/TAC</italic>
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC-1</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 267 268 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C10">10</xref>
###xml 512 514 512 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C10">10</xref></sup>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C11">11</xref>
###xml 856 858 856 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C11">11</xref></sup>
###xml 903 907 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 1000 1004 1000 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 180 188 <span type="species:ncbi:9606">patients</span>
Of the 25 TAS/TAC genes tested, TAC-1 [early growth responses 1 (EGR1)] was one of the most strongly upregulated genes commonly in the PBMCs of many vasculitis patients, as 96% of patients expressed this gene at 3-300-fold higher levels than healthy volunteers (Fig. 1A). EGR1 encodes a zinc finger transcription factor whose expression is induced within minutes upon the reception of growth stimuli; its expression then decays within a few hours. It promotes cellular differentiation along a macrophage lineage.10 It also plays a critical role in the response to both acute and chronic vascular stress by inducing the expression of several gene products linked to cellular perturbation. This is particularly true for the cellular perturbation in the vasculature that is induced by hypoxia, ischemia/reperfusion, atherosclerosis, and acute vascular injury.11 It remains unclear whether the induction of EGR1 in vasculitis is a pathogenic response or merely results from vascular stress. Nonetheless, EGR1 may serve as a gene marker for the diagnosis of vasculitis.
###end p 35
###begin p 36
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC-40</italic>
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C12">12</xref>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C12">12</xref></sup>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 500 501 500 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C4">4</xref>
###xml 500 501 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C4">4</xref></sup>
###xml 509 510 509 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C5">5</xref>
###xml 509 510 509 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C5">5</xref></sup>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C13">13</xref>
###xml 659 661 659 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C13">13</xref></sup>
###xml 701 705 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
###xml 449 457 <span type="species:ncbi:9606">patients</span>
###xml 608 616 <span type="species:ncbi:9606">patients</span>
TAC-40 (G0S2) is a lymphocyte G0/G1 switch gene that encodes a putative cell cycle inhibitor whose expression may be required before cells become committed to enter the G1 phase of the cell cycle.12 Nearly, half of the vasculitis patients showed >20-fold increased expression, whereas the expression of most of the normal volunteers was much lower (Fig. 1B). Notably, relative to healthy controls, G0S2 expression is also enhanced in the PBMCs from patients with other autoimmune diseases, namely SLE4 and RA.5 Microarray and qRT-PCR analyses also showed that G0S2 is upregulated in the PBMCs from psoriasis patients suffering from severe generalized disease.13 Thus, it may be interesting to analyze G0S2 further, as it may shed light on the pathogenesis of vasculitis at the molecular level (see below).
###end p 36
###begin p 37
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC-106</italic>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBD</italic>
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 260 261 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 268 269 260 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 274 275 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 277 279 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C14">14</xref>
###xml 277 279 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C14">14</xref></sup>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Nearly 77% of the vasculitis patients expressed 3-16-fold more TAC-106 (HBD) mRNA than the normal volunteers (Fig. 1C). HBD is a minor type of hemoglobin (it makes up only 2-3% of adult hemoglobin) that forms a complex with alpha-hemoglobin called hemoglobin A2 (alpha2delta2).14 Although high HbA2 levels are diagnostic for the beta-thalassemia trait, its relevance to vasculitis pathology is unknown. Nonetheless, it may be useful as a diagnostic gene marker for vasculitis.
###end p 37
###begin p 38
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C15">15</xref>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C15">15</xref></sup>
###xml 227 239 227 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Amphiregulin</italic>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C4">4</xref>
###xml 301 302 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C4">4</xref></sup>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C5">5</xref>
###xml 310 311 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C5">5</xref></sup>
###xml 418 430 418 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Amphiregulin</italic>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 459 471 459 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Amphiregulin</italic>
###xml 284 292 <span type="species:ncbi:9606">patients</span>
###xml 346 354 <span type="species:ncbi:9606">patients</span>
###xml 395 403 <span type="species:ncbi:9606">patients</span>
Amphiregulin is one of the epidermal growth factor (EGF)-like growth factors that stimulate cell growth by activating the EGF receptor signaling of target cells in an autocrine/juxtacrine fashion.15 We previously reported that Amphiregulin expression is enhanced in the PBMCs of some patients with SLE4 and RA.5 However, compared with SLE and RA patients, a far smaller proportion of vasculitis patients show enhanced Amphiregulin expression (Fig. 1D). Thus, Amphiregulin may be more significant as a DNA marker for SLE and RA than for vasculitis.
###end p 38
###begin p 39
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC30</italic>
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS10</italic>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C16">16</xref>
###xml 219 221 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C16">16</xref></sup>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC30</italic>
###xml 392 393 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
TAC30 (=TVAS10) encodes an uncharacterized novel protein that is composed primarily of an ankyrin repeat, which is one of the most frequently observed amino-acid motifs and is important for protein-protein interactions.16 About a half of the vasculitis patients showed 10-200-fold increased expression of TAC30, whereas healthy volunteers showed very low expression except for one case (Fig. 1E).
###end p 39
###begin p 40
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C17">17</xref>
###xml 368 370 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C17">17</xref></sup>
###xml 427 432 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1R2</italic>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
###xml 449 456 <span type="species:ncbi:9606">patient</span>
###xml 674 682 <span type="species:ncbi:9606">patients</span>
Interleukin-1 (IL1), a principal macrophage-derived cytokine, plays a pivotal role in the immuno-inflammatory process by triggering cell activation via its type I receptor (IL1R1); in contrast, its type II receptor (IL1R2) lacks the intracellular domain for IL1 signaling and functions as a potent, specific, and natural inhibitor of IL1 by acting as a decoy receptor.17 About half of the vasculitis patients showed 20-50-fold IL1R2 expression (one patient showed approximately300-fold expression), whereas healthy volunteers showed very low expression except for one case (). This increased expression of IL1R2 may be related to the vascular inflammation of the vasculitis patients.
###end p 40
###begin p 41
###xml 139 147 139 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS1-191</italic>
###xml 149 162 149 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin C</italic>
###xml 507 509 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C18">18</xref>
###xml 507 509 504 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C18">18</xref></sup>
###xml 561 574 558 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin C</italic>
###xml 803 816 788 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin B</italic>
###xml 818 826 803 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAS2-047</italic>
###xml 534 542 <span type="species:ncbi:9606">patients</span>
###xml 591 598 <span type="species:ncbi:9606">patient</span>
###xml 734 742 <span type="species:ncbi:9606">patients</span>
Three phagocyte-specific S100 proteins called calgranulin- A, -B, and -C act separately during calcium-dependent signaling. In particular, TAS1-191 (calgranulin C) secretion by tumor necrosis factor (TNF)- stimulated granulocytes causes target cell activation that results in the upregulated expression of proinflammatory cytokines such as TNF and IL1beta; the TNF that is released may then stimulate granulocytes to secrete more calgranulin C, thereby establishing a self-amplifying positive feedback loop.18 About 30% of vasculitis patients showed 10-50-fold calgranulin C expression (one patient showed approximately150-fold expression), whereas most of the healthy volunteers showed low expression (). In contrast, the vasculitis patients and normal volunteers did not differ in their expression of calgranulin B (TAS2-047) (data not shown).
###end p 41
###begin title 42
Expression pattern of TAS/TAC genes in PBMC
###end title 42
###begin p 43
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 79 91 79 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Amphiregulin</italic>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C5">5</xref>
###xml 233 234 233 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C5">5</xref></sup>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBD</italic>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS10</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1R2</italic>
###xml 286 299 286 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin C</italic>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F5">5</xref>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1R2</italic>
###xml 592 605 592 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin C</italic>
###xml 646 647 646 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 749 755 749 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS10</italic>
###xml 787 788 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 807 811 807 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 813 819 813 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS10</italic>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1R2</italic>
###xml 832 845 832 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin C</italic>
###xml 875 876 875 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 333 338 <span type="species:ncbi:9606">human</span>
###xml 1117 1125 <span type="species:ncbi:9606">patients</span>
###xml 1192 1200 <span type="species:ncbi:9606">patients</span>
We previously reported that G0S2 was primarily expressed in monocytes, whereas Amphiregulin was expressed in both monocytes, T cells and B cells by performing RT-PCR on multiple-tissue cDNA panels (MTC) from Clontech (Palo Alto, CA).5 To determine whether EGR1, HBD, TVAS10, IL1R2, and calgranulin C are also expressed in particular human blood cells, we conducted similar experiments. As shown in Fig. 5, EGR1 and IL1R2 were expressed ubiquitously in all lanes, albeit with varying intensities. cDNA from placenta, which also contains many blood cells, served as a control. All genes except calgranulin C were strongly expressed in activated CD4+ T cells (lane 8) and weakly expressed in activated mononuclear cells (aMNCs) (lane 7). Only EGR1 and TVAS10 were expressed in activated CD8+ T (lane 9) cells. EGR1, TVAS10, IL1R2, and calgranulin C were expressed in resting CD8+ T cells (T-suppressor/cytotoxic; lane 2) and monocytes (lane 4). These observations together indicate that these vasculitis-upregulated genes have similar expression profiles. Unfortunately, we could not perform this analysis on vasculitis patients because of the low numbers of PBMCs that we could obtain from the patients.
###end p 43
###begin p 44
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBD</italic>
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS10</italic>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1R2</italic>
###xml 82 95 82 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin C</italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cal C</italic>
###xml 207 214 207 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">. GAPDH</italic>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 805 810 <span type="species:ncbi:9606">human</span>
Determination of the human blood cells that express EGR1, HBD, TVAS10, IL1R2, and calgranulin C (Cal C). RT-PCR was performed by using the multiple-tissue cDNA panel for human blood fractions (MTC, Clontech). GAPDH was also amplified as a loading control. PCR amplifications were conducted at 50degreesC over 33 cycles except as indicated at the right of the panels by # (50degreesC over 30 cycles). Lane 1, mononuclear cells (B, T cells, and monocytes). Lane 2, resting CD8+ cells (T-suppressor/cytotoxic cells). Lane 3, resting CD4+ cells (T-helper/inducer). Lane 4, resting CD14+ cells (monocytes). Lane 5, resting CD19+ cells (B cells). Lane 6, activated CD19+ cells (aCD10 +). Lane 7, activated mononuclear cells (aMNC). Lane 8, activated CD4+ cells (aCD8 + ). Lane 9, activated CD8+ cells. Lane 10, human placenta, which also includes many blood cells. The latter lane served as a control.
###end p 44
###begin title 45
###xml 15 30 <span type="species:ncbi:10090">transgenic mice</span>
Preparation of transgenic mice that overexpress G0S2
###end title 45
###begin p 46
###xml 381 382 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C7">7</xref>
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C7">7</xref></sup>
###xml 1167 1168 1167 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F2">2</xref>
###xml 2110 2111 2110 2111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 2146 2147 2146 2147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 176 191 <span type="species:ncbi:10090">transgenic mice</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 288 293 <span type="species:ncbi:9606">human</span>
###xml 430 435 <span type="species:ncbi:10090">mouse</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
###xml 525 540 <span type="species:ncbi:10090">transgenic mice</span>
###xml 755 770 <span type="species:ncbi:10090">transgenic mice</span>
###xml 946 951 <span type="species:ncbi:10090">mouse</span>
###xml 1018 1022 <span type="species:ncbi:10090">mice</span>
###xml 1060 1065 <span type="species:ncbi:9606">human</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1197 1202 <span type="species:ncbi:10090">mouse</span>
###xml 1261 1265 <span type="species:ncbi:10090">mice</span>
###xml 1364 1369 <span type="species:ncbi:10090">mouse</span>
###xml 1409 1414 <span type="species:ncbi:10090">mouse</span>
###xml 1574 1579 <span type="species:ncbi:10090">mouse</span>
###xml 1605 1620 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1657 1661 <span type="species:ncbi:10090">mice</span>
###xml 1674 1679 <span type="species:ncbi:9606">human</span>
###xml 1739 1744 <span type="species:ncbi:10090">mouse</span>
###xml 1814 1819 <span type="species:ncbi:10090">mouse</span>
###xml 1855 1860 <span type="species:ncbi:10090">mouse</span>
###xml 1897 1901 <span type="species:ncbi:10090">mice</span>
###xml 1934 1939 <span type="species:ncbi:9606">human</span>
###xml 2027 2042 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2083 2087 <span type="species:ncbi:10090">mice</span>
###xml 2166 2181 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2237 2241 <span type="species:ncbi:10090">mice</span>
###xml 2280 2295 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2398 2413 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2468 2473 <span type="species:ncbi:9606">human</span>
###xml 2497 2512 <span type="species:ncbi:10090">transgenic mice</span>
We selected G0S2 for further analysis because little is known about its physiological significance and function. To explore the physiological significance of G0S2, we prepared transgenic mice that overexpress the human gene for G0S2. For this purpose, we constructed plasmid DNA in which human G0S2 cDNA lies directly downstream of the beta-actin promoter, as described previously.7 This construct was used to generate transgenic mouse lines that express human G0S2 protein in all tissues. The successful generation of these transgenic mice was confirmed by PCR and/or western blot analysis using DNA or cell extracts obtained from the tail. Expression of G0S2 protein was confirmed by the monoclonal antibody (#3-1) we prepared here (see ). Although the transgenic mice did not exhibit an obvious phenotype, they seemed to be unhealthy as they did not produce large numbers of offspring. This made it very difficult to establish this transgenic mouse line. For example, in the first attempt to generate this line, 61 mice were tested by PCR for expression of human G0S2. Of these, three female and three male mice were found to bear the transgene (GTG1a-f, see Fig. 2). However, the GTG1f female mouse died soon after birth and the GTG1e female and GTG1c male mice died 3 and 1 months after birth, respectively (). Moreover, while the surviving female transgenic mouse (GTG1d) produced one female transgenic mouse, which safely grew to adulthood, the mother died during her next pregnancy. Her daughter also died during her first pregnancy. In addition, the surviving male mouse GTG1b only produced male transgenic mice when mated with wild-type B6 female mice because the human G0S2 gene was introduced into the Y chromosome. Thus, this mouse could not be used further. Furthermore, the remaining surviving male mouse, GTG1a, did not produce transgenic mouse when mated with wild-type B6 female mice. Thus, we failed to establish a human G0S2-expressing transgenic strain in this trial. The second trial did not generate any transgenic mice. However, in the third trial, of the 22 mice examined by PCR (Fig. 6A) and western blot analysis (Fig. 6B), we found three transgenic mice, of which one (GTG3a) produced offspring (see ). These mice appear to be healthier than the other transgenic mice and consequently we have been able to maintain this line probably due to lower G0S2 levels than other transgenic mice. Thus, the exogenous and ubiquitous overexpression of human G0S2 seems to make the transgenic mice unhealthy and inhibits their production of offspring.
###end p 46
###begin p 47
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 117 118 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 154 158 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 281 282 281 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 684 685 684 685 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1075 1076 1075 1076 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1081 1082 1081 1082 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1090 1091 1090 1091 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1096 1097 1096 1097 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 22 37 <span type="species:ncbi:10090">transgenic mice</span>
###xml 99 114 <span type="species:ncbi:10090">transgenic mice</span>
###xml 159 174 <span type="species:ncbi:10090">transgenic mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 250 255 <span type="species:ncbi:10090">mouse</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 511 516 <span type="species:ncbi:9606">human</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 924 929 <span type="species:ncbi:10090">mouse</span>
Establishment of G0S2 transgenic mice. (A) An example of the RT-PCR analyses used to identify G0S2 transgenic mice. (B) Western blot analysis to identify G0S2 transgenic mice. The panel for ATG3-F1 and -F2 mice is shown as an example. The transgenic mouse numbers are underlined. (C) ISH analyses of G0S2-TG mice. Sections from the kidney (i), stomach (ii, mucosa; v, smooth muscle), esophagus (iii), heart (iv), and epididymis (vi) of adult G0S2-TG mice (GTG1b is shown as an example) were hybridized with the human G0S2 antisense probe and colored blue by using the alkaline phosphatase reaction. The nuclei were counterstained with nuclear fast red. Original magnification: x200. (D) Immunological detection of exogenic G0S2 proteins in various organs of G0S2-TG mice (GTG1b is shown as an example). Sections from the kidney (i), stomach (ii), lung (iii), and heart (iv) of the adult G0S2-TG mice were incubated with the mouse monoclonal anti-G0S2 antibody (#3-1) and stained with diaminobenzidine. The nuclei were counterstained with hematoxylin. Original magnification: A and B, x200; C and D, x400.
###end p 47
###begin title 48
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 34 49 <span type="species:ncbi:10090">transgenic mice</span>
Human G0S2 expression patterns in transgenic mice
###end title 48
###begin p 49
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
To examine the expression patterns of exogenous human G0S2 in various transgenic mouse tissues, we first performed ISH analysis. As shown in some representative pictures (Fig. 6C), high-level expression of G0S2 mRNA was detected in various organs and tissues. The signals in the urinary tubule, gastric foveola, and esophageal mucosa were distributed in epithelial clumps (Fig. 6Ci-iii). In contrast, scattered or diffusely distributed signals were detected in the cardiac ventricle, gastric smooth muscle, and seminiferous tubule (Fig. 6Civ-vi).
###end p 49
###begin p 50
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 524 525 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 643 644 643 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 159 174 <span type="species:ncbi:10090">transgenic mice</span>
Immunohistochemical analysis using the monoclonal antibody (#3-1) also detected exogenously expressed human G0S2 proteins in various organs and tissues of the transgenic mice. As shown in some representative pictures (Fig. 6D), the cellular distribution pattern of these proteins was similar to that of exogenous G0S2 mRNA (Fig. 6C). In the kidney, although most urinary tubule epithelia were weakly positive for G0S2, other epithelia expressed this protein at high levels; the latter epithelia also existed in clumps (Fig. 6Di). A similar patchy distribution of strong G0S2 signals was detected in the foveolar epithelia of the stomach (Fig. 6Dii). In the lung and heart, there was a scattered distribution of exogenous G0S2 signals in the alveolar epithelium and a diffuse distribution in cardiac ventricular muscle, respectively (Fig. 6Diii and iv).
###end p 50
###begin title 51
###xml 19 34 <span type="species:ncbi:10090">transgenic mice</span>
Phenotypes of G0S2 transgenic mice
###end title 51
###begin p 52
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F7">7</xref>
###xml 862 863 854 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F7">7</xref>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 98 113 <span type="species:ncbi:10090">transgenic mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 651 666 <span type="species:ncbi:10090">transgenic mice</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
To explore the phenotypes of the G0S2 transgenic mouse, we first subjected various organs of G0S2 transgenic mice and wild-type (C57BL/6) mice to histological examination. Obvious histopathological findings that related directly to vasculitis were not observed. Notably, microabscess-like panniculitis lesions were detected in the dermis and subcutaneous fat tissue (Fig. 7A). Of the eight TG mice examined, such lesions were detected in three. We also measured the serum levels of two autoimmunity-related antibodies, namely, anti-nuclear antibody (ANA) and anti-dsDNA antibody. We found both were increased in G0S2 TG mice: the OD490 for ANA in the transgenic mice was 0.359 +/- 0.170 [compared with 0.219 +/- 0.044 for wild-type (B6) mice], whereas the OD490 for anti-dsDNA antibody was 0.294 +/- 0.090 (compared with 0.188 +/- 0.038 in wild-type mice) (Fig. 7B). However, these differences did not reach statistical significance, in part, because of the limited number of G0S2 TG mice we could use for these measurements. Taken together, it appears that G0S2 may participate in the pathogenesis of autoimmune diseases in general, and in particular, it may be related to inflammation.
###end p 52
###begin p 53
###xml 58 59 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 389 390 389 390 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 663 664 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 678 679 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 738 739 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
Histological and serological phenotypes of G0S2-TG mice. (A) Histological phenotype of G0S2-TG mice (GTG1b is shown as an example). Sections of the back skin of adult G0S2-TG mice were stained with hematoxylin and eosin. A boxed area in the left panel is enlarged in the right to show microabscess lesions containing numerous neutrophils. Original magnification: left, x100; right, x400. (B) Serological phenotypes of G0S2-TG mice (GTG1a is shown as an example). The sera from adult C57BL/6 (open circle) or G0S2-TG (closed circle) mice were examined for the levels of ANA and anti-dsDNA antibody. Asterisk and double asterisks indicate 'not significant' because P = 0.1011 and P = 0.0526, respectively, as determined by the Mann-Whitney U-test of differences between G0S2-TG and wild-type mice. The G0S2 TG mice examined are designated as follows: a (GTG1a), b (GTG1b), c (GTG1b-F1a), d (GTG1b-F2a), and e (GTG1b-F1c). The values of individual mice are plotted.
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F3">3</xref>
###xml 572 573 572 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F4">4</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSN014TB1">1</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSN014TB2">2</xref>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 637 641 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 643 646 643 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HBD</italic>
###xml 648 654 648 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TVAS10</italic>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL1R2</italic>
###xml 663 675 663 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Amphiregulin</italic>
###xml 681 694 681 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">calgranulin C</italic>
###xml 764 765 764 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 900 901 900 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F5">5</xref>
###xml 978 982 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 1023 1024 1023 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C5">5</xref>
###xml 1023 1024 1023 1024 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C5">5</xref></sup>
###xml 405 413 <span type="species:ncbi:9606">patients</span>
###xml 749 757 <span type="species:ncbi:9606">patients</span>
In the present study, we report candidate gene markers for vasculitis that may be useful for diagnosing and understanding the basic pathogenesis of vasculitis and other autoimmune diseases such as SLE. These genes were identified by stepwise subtraction and cDNA microarray techniques, which permitted us to comprehensively isolate the genes that show augmented mRNA expression in the PBMCs of vasculitis patients when compared with normal volunteers. The vasculitis-specific upregulation of these genes was validated with northern blot and/or RT-PCR analyses (Figs 3 and 4, Tables 1 and 2). We then showed by RT-PCR analysis that EGR1, G0S2, HBD, TVAS10, IL1R2, Amphiregulin, and calgranulin C are frequently upregulated in the PBMCs of vasculitis patients (Fig. 1 and ). MTC analysis revealed that in normal PBMCs, these genes are expressed primarily by monocytes and/or activated CD4+ cells (Fig. 5). We also showed previously using different primers and PCR conditions that G0S2 is predominantly expressed by monocytes.5 These results suggest that monocytes, including macrophages, express these vasculitis-upregulated genes and thus may play a role in the pathogenesis of vasculitis.
###end p 55
###begin p 56
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSN014TB3">3</xref>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 761 765 761 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 819 820 819 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C4">4</xref>
###xml 819 820 819 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C4">4</xref></sup>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C10">10</xref>
###xml 916 918 916 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C10">10</xref></sup>
###xml 932 936 932 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C19">19</xref>
###xml 988 990 988 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C19">19</xref></sup>
###xml 1065 1069 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
###xml 664 672 <span type="species:ncbi:9606">patients</span>
###xml 810 818 <span type="species:ncbi:9606">patients</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1094 1102 <span type="species:ncbi:9606">patients</span>
We noticed that several putative vasculitis-upregulated genes also show upregulated expression in other autoimmune diseases, namely, SLE and RA (Table 3). Of these, EGR1 is particularly interesting as the degree to which it is upregulated in most vasculitis patients is remarkable (Fig. 1A). EGR1 is induced by a variety of cellular stresses, including hypoxia, and may function as a master switch that triggers the expression of numerous key inflammatory mediators. In particular, EGR1 induces a number of gene products that have been linked to cellular perturbation, especially in the vasculature. Moreover, many of these genes are often induced in the PBMCs of patients afflicted with a variety of autoimmune diseases. For example, we showed previously that EGR1 is markedly upregulated in the PBMCs of SLE patients.4 It also plays a critical role in promoting cellular differentiation along a macrophage lineage.10 Nonetheless, EGR1-null mice are viable and develop and grow normally.19 Rigorous analyses will be needed to determine whether the upregulation of EGR1 mRNA in many vasculitis patients is pathogenically significant or merely an associated phenomenon.
###end p 56
###begin p 57
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC/TAS</italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
List of the TAC/TAS genes that also show upregulated expression in PBMCs from SLE and RA patients
###end p 57
###begin p 58
The numbers represent fold change compared with normal volunteers; nc, no conspicuous change between RA and control.
###end p 58
###begin p 59
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F1">1</xref>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C20">20</xref>
###xml 275 277 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C20">20</xref></sup>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C21">21</xref>
###xml 497 499 497 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C21">21</xref></sup>
###xml 576 580 576 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C22">22</xref>
###xml 676 678 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C22">22</xref></sup>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C13">13</xref>
###xml 825 827 825 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C13">13</xref></sup>
###xml 864 868 864 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 963 964 963 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C4">4</xref>
###xml 963 964 963 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C4">4</xref></sup>
###xml 972 973 972 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C5">5</xref>
###xml 972 973 972 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C5">5</xref></sup>
###xml 973 977 973 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 1228 1232 1228 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 1376 1378 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSN014C23">23</xref>
###xml 1376 1378 1368 1370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSN014C23">23</xref></sup>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 394 399 <span type="species:ncbi:9606">women</span>
###xml 544 549 <span type="species:ncbi:9606">human</span>
###xml 735 743 <span type="species:ncbi:9606">patients</span>
###xml 922 930 <span type="species:ncbi:9606">patients</span>
G0S2 also displayed enhanced expression in many vasculitis patients (Fig. 1B). G0S2 was first identified as one of the G0/G1 switch (G0S) genes that are differentially expressed in lymphocytes during their lectin-induced switch from the G0 to the G1 phases of the cell cycle.20G0S2 is one of the genes that is upregulated during normal implantation but its expression is significantly lower in women with endometriosis that is associated with pelvic pain and infertility with implantation failure.21 In a replicative senescence model employing human dermal fibroblasts (HDF), G0S2 expression was upregulated in old HDF cells, which suggests that it participates in senescence.22 Microarray and qRT-PCR analyses of PBMCs from psoriasis patients suffering from severe generalized disease also revealed the upregulation of G0S2.13 Moreover, we showed previously that G0S2 mRNA levels are markedly increased in the PBMCs from patients with the autoimmune diseases SLE4 and RA.5G0S2 is a putative target gene of peroxisome-proliferator-activated receptor (PPAR) alpha, which belongs to a group of transcription factors that are involved in numerous processes, including lipid metabolism and adipogenesis. Moreover, it was shown that G0S2 is upregulated after PPARdelta activation and that it may be involved in the PPARdelta-mediated mitigation of cardiac fibroblast proliferation.23
###end p 59
###begin p 60
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F6">6</xref>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F2">2</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F7">7</xref>
###xml 595 596 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSN014F7">7</xref>
###xml 914 918 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 402 408 <span type="species:ncbi:10090">murine</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 482 486 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
We here generated G0S2-TG mice that ubiquitously overexpress G0S2 proteins (Fig. 6). We showed that these mice are unhealthy as they do not produce many offspring (Fig. 2) and frequently display formations of microabscess-like panniculitis lesions in the dermis and subcutaneous fat tissue (Fig. 7A). The development of these microabscess-like panniculitis lesions may reflect the dysregulation of the murine immune system in these mice. Supporting this is that some of the G0S2-TG mice had augmented levels of immunodeficiency-related anti-nuclear and anti-dsDNA antibodies in their sera (Fig. 7B), although these phenotypes are related not to vasculitis but to SLE. It should be noted, however, that these serum differences did not achieve statistical significance, largely because of the shortage of G0S2-TG mice. It will be necessary to study larger numbers of G0S2-TG mice to confirm this association between G0S2 overexpression and the development of autoimmune features. Should this association be confirmed, the high-quality polyclonal and monoclonal anti-G0S2 antibodies that we produced may be useful as tools (perhaps in enzyme-linked EIA) for diagnosing not just vasculitis but also other autoimmune diseases.
###end p 60
###begin p 61
###xml 60 68 <span type="species:ncbi:9606">patients</span>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 479 486 <span type="species:ncbi:9606">patient</span>
###xml 573 580 <span type="species:ncbi:9606">patient</span>
###xml 928 936 <span type="species:ncbi:9606">patients</span>
We performed this study on a highly heterogeneous cohort of patients, including those with systemic vasculitis. All of these diseases share the inflammatory involvement of blood vessels. However, their target organs, pathogenic mechanisms, clinical findings, and outcomes are quite different. Moreover, although the disease activity status in these patients was heterogeneous and some were receiving corticosteroid or immunosuppressive therapy, these factors were ignored in our patient recruitment protocol. Nonetheless, despite these marked heterogeneous features of our patient population, we could isolate putative common genes that are upregulated, which was our original goal. We are currently performing in parallel the expression profiling of the genes that are up- or downregulated in each individual disease and analyzing these profiles in terms of the symptoms, disease activity status, and clinical treatment of the patients. However, the results obtained from such studies are highly complex, which has hampered the identification of candidate gene markers that can be used for diagnosis.
###end p 61
###begin p 62
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGR1</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G0S2</italic>
Taken together, we conclude that the putative gene markers we identified here, in particular EGR1 and G0S2, may be useful for diagnosing not only vasculitis but also other autoimmune diseases, perhaps by qRT-PCR and antibody-based methods. Other, as yet uncharacterized, genes that we detected as being upregulated in vasculitis may also be useful candidate gene markers and thus are worth further detailed analysis. In particular, the identification of the functions of these genes may reveal the hitherto unknown mechanism(s) that underlie the pathogenesis of vasculitis. This in turn may shed light on therapeutic avenues for treating vasculitis.
###end p 62
###begin title 63
Supplementary Data
###end title 63
###begin p 64
.
###end p 64
###begin title 65
Funding
###end title 65
###begin p 66
###xml 724 730 <span type="species:ncbi:8164">Suzuki</span>
This work was primarily supported by a grant-in-aid from the Health Science Research grant from the Ministry of Health and Welfare of Japan. This work was also supported in part by grants-in-aid to Hiroshi Nojima from Bio-Medical Cluster Project In Saito, Innovation Plaza Osaka and Regional Research and Development Resources Utilization Program of the Japan Science, and Technology Agency (JST), Scientific Research on Priority Areas "Applied Genomics", Scientific Research (S), Exploratory Research, and the Science and Technology Incubation Program in Advanced Regions from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Moreover, this study was partly supported by grants-in-aid to Kazuo Suzuki and Hiroshi Hashimoto from the Ministry of Health and Welfare of Japan.
###end p 66
###begin title 67
Supplementary Material
###end title 67
###begin title 68
[Supplementary Data]
###end title 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAC</italic>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 292 307 <span type="species:ncbi:10090">transgenic mice</span>
We thank the patients and healthy volunteers who participated in this study. We are obliged to Prof. Masaru Okabe, Prof. Masahito Ikawa, Ms Yumi Koreeda, Mr Masato Tanaka, Ms Yoko Esaki, Ms Akiko Kawai, and Ms Hisae Takema for useful advice and technical assistance in the generation of G0S2 transgenic mice. We also thank Ms Azumi Fujimori, Ms Chie Ishigami, Ms Ayami Ohtaka, Mr Akira Shigehisa, Dr Jun Sato, and Dr Takashi Kasama for technical assistance in the identification of TAC genes, and Dr Patrick Hughes for critically reading the manuscript.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Nomenclature of systemic vasculitides. Proposal of an international consensus conference
###end article-title 72
###begin article-title 73
ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs
###end article-title 73
###begin article-title 74
Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis
###end article-title 74
###begin article-title 75
###xml 118 126 <span type="species:ncbi:9606">patients</span>
Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients
###end article-title 75
###begin article-title 76
###xml 121 129 <span type="species:ncbi:9606">patients</span>
Isolation and expression profiling of genes upregulated in bone marrow-derived mononuclear cells of rheumatoid arthritis patients
###end article-title 76
###begin article-title 77
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Use of stepwise subtraction to comprehensively isolate mouse genes whose transcription is up-regulated during spermiogenesis
###end article-title 77
###begin article-title 78
A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP)
###end article-title 78
###begin article-title 79
Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its downregulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma
###end article-title 79
###begin article-title 80
Large scale isolation of osteoclast-specific genes by an improved method involving the preparation of a subtracted cDNA library
###end article-title 80
###begin article-title 81
The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage
###end article-title 81
###begin article-title 82
Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis
###end article-title 82
###begin article-title 83
###xml 87 92 <span type="species:ncbi:9606">human</span>
Cyclosporin A inhibits early mRNA expression of G0/G1 switch gene 2 (G0S2) in cultured human blood mononuclear cells
###end article-title 83
###begin article-title 84
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules
###end article-title 84
###begin article-title 85
###xml 40 45 <span type="species:ncbi:9606">human</span>
Structure and in vitro transcription of human globin genes
###end article-title 85
###begin article-title 86
###xml 116 121 <span type="species:ncbi:9606">human</span>
Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7
###end article-title 86
###begin article-title 87
The ankyrin repeat as molecular architecture for protein recognition
###end article-title 87
###begin article-title 88
The interleukin 1 receptor family
###end article-title 88
###begin article-title 89
Proinflammatory S100 proteins in arthritis and autoimmune disease
###end article-title 89
###begin article-title 90
Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A
###end article-title 90
###begin article-title 91
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated
###end article-title 91
###begin article-title 92
###xml 41 46 <span type="species:ncbi:9606">women</span>
Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility
###end article-title 92
###begin article-title 93
###xml 58 63 <span type="species:ncbi:9606">human</span>
Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology
###end article-title 93
###begin article-title 94
The G0/G1 switch gene 2 is a novel PPAR target gene
###end article-title 94

